Brief: Stereotaxis And Abbott Announce Global Collaboration Combining Leading Mapping And Robotic Technologies To Improve Treatment Of Abnormal Heart Rhythms
19/05/2023 14:44
Stereotaxis Inc STXS.A :
* STEREOTAXIS AND ABBOTT ANNOUNCE GLOBAL COLLABORATION
COMBINING
LEADING MAPPING AND ROBOTIC TECHNOLOGIES TO IMPROVE TREATMENT OF
ABNORMAL HEART RHYTHMS
* STEREOTAXIS INC - INTEGRATED TECHNOLOGIES ARE CLEARED FOR
USE IN
EUROPE WITH ADDITIONAL REGULATORY CLEARANCES EXPECTED IN COMING
MONTHS
Source text for Eikon: ID:nGNXbC4cYB
Further company coverage: STXS.A
Recent news on Stereotaxis
See all newsSurgical robotics provider Stereotaxis' Q1 revenue misses analyst estimates
Stereotaxis rises after FDA clears new heart-procedure platform
Surgical robotics firm Stereotaxis Q4 revenue jumps
Brief: Stereotaxis Q4 Revenue USD 8.642 Million
Brief: Stereotaxis Receives FDA Approval For Magic Ablation Catheter